Literature DB >> 23704201

Effect of multiple invasive foci on breast cancer outcomes according to the molecular subtypes: a report from the Korean Breast Cancer Society.

H G Moon1, W Han, J Y Kim, S J Kim, J H Yoon, S J Oh, J H Yu, D Y Noh.   

Abstract

BACKGROUND: In this study, the prognostic impact of the presence of the multifocal or multicentric tumor (MMT) and its association with molecular subtypes were investigated. PATIENTS AND METHODS: We investigated the breast cancer metastasis and survival in patients with multifocal or multicentric invasive foci in the same breast. The study population includes 2882 patients in the Seoul National University Hospital Breast Care Center (SNUHBCC) dataset and 41 179 patients in Korean Breast Cancer Registry (KBCR) dataset.
RESULTS: From SNUHBCC dataset, we observed a significant role of MMT in developing distant metastasis and death when the tumors were triple-negative subtype. This subtype-specific prognostic importance of MMT in overall survival was also seen in KBCR dataset (HR, 1.32; 95% CI, 1.02-1.69). In tumors <2 cm, the hazard ratios (HRs) for node metastasis and death were similar along the tumor size change in triple-negative subtype, while other subtypes showed a stepwise increment, suggesting the biologic importance of small invasive foci in this subtype.
CONCLUSIONS: Our results demonstrate the prognostic importance of MMT in patients with triple-negative breast cancers. Small additional invasive foci in triple-negative breast cancer patients should be considered as clinically relevant tumor deposits.

Entities:  

Keywords:  breast cancer; molecular subtype; multicentricity; multifocality; prognosis

Mesh:

Year:  2013        PMID: 23704201     DOI: 10.1093/annonc/mdt187

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  7 in total

Review 1.  Evaluating the current evidence to support therapeutic mammoplasty or breast-conserving surgery as an alternative to mastectomy in the treatment of multifocal and multicentric breast cancers.

Authors:  Zoe Ellen Winters; Lorenzo Bernaudo
Journal:  Gland Surg       Date:  2018-12

2.  Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.

Authors:  Lei Wang; Xin Hu; Peng Wang; Zhi-Ming Shao
Journal:  Oncologist       Date:  2018-08-06

3.  The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers.

Authors:  Hyeong-Gon Moon; Namshin Kim; Seongmun Jeong; Minju Lee; HyunHye Moon; Jongjin Kim; Tae-Kyung Yoo; Han-Byoel Lee; Jisun Kim; Dong-Young Noh; Wonshik Han
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

4.  The Prognostic Impact of Synchronous Ipsilateral Multiple Breast Cancer: Survival Outcomes according to the Eighth American Joint Committee on Cancer Staging and Molecular Subtype.

Authors:  Jinah Chu; Hyunsik Bae; Youjeong Seo; Soo Youn Cho; Seok-Hyung Kim; Eun Yoon Cho
Journal:  J Pathol Transl Med       Date:  2018-10-23

5.  Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort.

Authors:  Homero Gonçalves; Maximiliano Ribeiro Guerra; Jane Rocha Duarte Cintra; Vívian Assis Fayer; Igor Vilela Brum; Maria Teresa Bustamante Teixeira
Journal:  Clin Med Insights Oncol       Date:  2018-07-27

Review 6.  Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.

Authors:  Z E Winters; J Horsnell; K T Elvers; A J Maxwell; L J Jones; A M Shaaban; P Schmid; N R Williams; A Beswick; R Greenwood; J C Ingram; C Saunders; J S Vaidya; L Esserman; I Jatoi; A M Brunt
Journal:  BJS Open       Date:  2018-05-22

7.  Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data.

Authors:  Sung Hyouk Choi; Kyoung-Eun Kim; Yujin Park; Young Wook Ju; Ji-Gwang Jung; Eun Shin Lee; Han-Byoel Lee; Wonshik Han; Dong-Young Noh; Hyung-Jin Yoon; Hyeong-Gon Moon
Journal:  Breast       Date:  2020-08-19       Impact factor: 4.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.